AUS
NZ
UK
CA
USA
IND
Source: Bukhta Yurii, Shutterstock
Summary
- IM Cannabis and IDEX Biometrics are expected to begin trading on the North American markets on Monday, March 1.
- Stocks of IM Cannabis are currently listed on the Canadian Securities Exchange (CSE), which post a growth of almost 533 per cent for the past year.
- IDEX Biometrics reeled in a revenue of US$ 598 thousand in the fourth quarter of 2020, up from that of US$ 71 thousand in Q4 2019.
March is poised to be a busy month for public listing debuts, with major firm firms such as gaming giant Roblox and cryptocurrency exchange Coinbase in the pipeline to go public. As we begin the month, let’s take a look companies IM Cannabis and IDEX Biometrics that are expected to begin trading on the North American markets on Monday, March 1.
IM Cannabis Corp
Medical marijuana company IM Cannabis Corp, also known as IMC, announced last week (February 25) that its application to get listed on the Nasdaq Capital Markets has been greenlit. Its shares are scheduled to begin trading on the Nasdaq platform, under the ticker of ‘IMCC’, from March 1 onwards, the company said.
The pot company manufactures government-licensed cannabis products for whole sale as well as retail clients. With operations in Germany and Israel, IMC reportedly has assets in Greece, a subsidiary in Portugal and expansion plans in the Netherlands.
Stocks of IM Cannabis are listed on the Canadian Securities Exchange (CSE), which currently post a growth of almost 533 per cent for the past year.
©Kalkine Group 2021
IDEX Biometrics
Norwegian tech firm IDEX Biometrics announced on Wednesday, February 24, that its American Depositary Shares (ADS) are scheduled to hit the Nasdaq Capital Market on March 1 trading under the symbol ‘IDBA’. The Oslo-based company has reportedly registered around 800,000 ADSs, each of which represents 75 ordinary shares, at the price of about US$ 24.75 apiece.
Stocks of IDEX Biometrics are currently listed on the Norwegian stock market of Oslo Børs, which is managed by the Oslo Stock Exchange, under the ticker symbol of ‘IDEX’.
The fingerprint technology reeled in a revenue of US$ 598 thousand in the fourth quarter of 2020, up from that of US$ 71 thousand in Q4 2019. On an annual level, IDEX Biometrics’ revenue stood at US$ 1.1 million in 2020.
